Literature DB >> 33472537

Target-capture full-length double-strand cDNA sequencing for alternative splicing analysis.

Hiroki Ura1,2, Sumihito Togi1,2, Yo Niida1,2.   

Abstract

Alternative splicing is a regulated process by which eukaryotic genes may produce diverse biological products. Defects in the process typically affect cellular function and can lead to disease. Next-generation sequencing (NGS) technologies have been developed to detect alternative splicing events; however, the alternative splicing events detected by standard RNA-Seq may or may not be derived from full-length RNA. The SMARTer method provides full-length double-strand cDNA synthesis, and the resulting gene expression patterns correlate strongly with standard RNA-Seq. However, it also yields non-specific genomic DNA amplification. We improved the SMARTer method by employing a target-capture full-length double-strand cDNA sequencing method. High-fidelity, full-length cDNA is generated by the SMARTer method, followed by target-specific capture with exon probes. The expression pattern observed with this SMARTer Capture method was highly correlated with the results of the original SMARTer method. The number and accuracy of the detected splicing events were increased by eliminating non-specific genomic DNA amplification by the SMARTer Capture. Compared to the original SMARTer method, the SMARTer Capture provided 4-fold greater detection of alternative splicing events at the same read number, and it took less than 1/100 of read number to detect the same number of splicing events. The percent splicing in index (PSI) of the SMARTer Capture is highly correlated with the PSI of the SMARTer. These results indicate that the SMARTer Capture represents an improvement of the SMARTer method to accurately characterize alternative splicing repertories in targeted genes without biases.

Entities:  

Keywords:  Alternative splicing; RNA-Sequencing (RNA-Seq); full-length double-strand cDNA; next-generation sequencing; splicing variant; target-capture

Mesh:

Substances:

Year:  2021        PMID: 33472537      PMCID: PMC8594882          DOI: 10.1080/15476286.2021.1872961

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  28 in total

1.  Full-length RNA-seq from single cells using Smart-seq2.

Authors:  Simone Picelli; Omid R Faridani; Asa K Björklund; Gösta Winberg; Sven Sagasser; Rickard Sandberg
Journal:  Nat Protoc       Date:  2014-01-02       Impact factor: 13.491

Review 2.  Nanopore sequencing: Review of potential applications in functional genomics.

Authors:  Nobuaki Kono; Kazuharu Arakawa
Journal:  Dev Growth Differ       Date:  2019-04-29       Impact factor: 2.053

Review 3.  Alternative splicing and the evolution of phenotypic novelty.

Authors:  Stephen J Bush; Lu Chen; Jaime M Tovar-Corona; Araxi O Urrutia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-02-05       Impact factor: 6.237

Review 4.  Mechanistic insights into precursor messenger RNA splicing by the spliceosome.

Authors:  Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-27       Impact factor: 94.444

5.  SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation.

Authors:  Wei Shen; Shuai Le; Yan Li; Fuquan Hu
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

Review 6.  Splice variants as cancer biomarkers.

Authors:  Brigitta M N Brinkman
Journal:  Clin Biochem       Date:  2004-07       Impact factor: 3.281

7.  Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development.

Authors:  Jimena Giudice; Zheng Xia; Eric T Wang; Marissa A Scavuzzo; Amanda J Ward; Auinash Kalsotra; Wei Wang; Xander H T Wehrens; Christopher B Burge; Wei Li; Thomas A Cooper
Journal:  Nat Commun       Date:  2014-04-22       Impact factor: 14.919

8.  Dual Deep Sequencing Improves the Accuracy of Low-Frequency Somatic Mutation Detection in Cancer Gene Panel Testing.

Authors:  Hiroki Ura; Sumihito Togi; Yo Niida
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

9.  Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.

Authors:  Ravi K Singh; Zheng Xia; Christopher S Bland; Auinash Kalsotra; Marissa A Scavuzzo; Tomaz Curk; Jernej Ule; Wei Li; Thomas A Cooper
Journal:  Mol Cell       Date:  2014-07-31       Impact factor: 17.970

Review 10.  Translating RNA sequencing into clinical diagnostics: opportunities and challenges.

Authors:  Sara A Byron; Kendall R Van Keuren-Jensen; David M Engelthaler; John D Carpten; David W Craig
Journal:  Nat Rev Genet       Date:  2016-03-21       Impact factor: 53.242

View more
  3 in total

1.  Poly(A) capture full length cDNA sequencing improves the accuracy and detection ability of transcript quantification and alternative splicing events.

Authors:  Hiroki Ura; Sumihito Togi; Yo Niida
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  A comparison of mRNA sequencing (RNA-Seq) library preparation methods for transcriptome analysis.

Authors:  Hiroki Ura; Sumihito Togi; Yo Niida
Journal:  BMC Genomics       Date:  2022-04-13       Impact factor: 3.969

3.  Targeted Double-Stranded cDNA Sequencing-Based Phase Analysis to Identify Compound Heterozygous Mutations and Differential Allelic Expression.

Authors:  Hiroki Ura; Sumihito Togi; Yo Niida
Journal:  Biology (Basel)       Date:  2021-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.